Jeannine Delaney

Jeannine Delaney currently serves as the Head of R&D at Adeptrix Corporation, providing leadership in the development of human fluid biomarker assays aimed at improving the understanding and treatment of neurodegenerative diseases. With extensive experience in analytical R&D, Jeannine held the position of Sr. Director Analytical R&D at Centessa Pharmaceuticals and Senior Principal Scientist at UCB, where responsibilities included managing analytical chemistry activities and authoring critical regulatory submissions. Previous roles at Insulet Corporation, PerkinElmer, VisEn Medical Inc., and Pfizer RTC further highlight Jeannine's expertise in method development, characterization of drug substances, and management of laboratory operations. Jeannine holds a Ph.D. in Bio-Analytical Chemistry from Northeastern University and a BASc in Chemistry from the University of Massachusetts Lowell.